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INTRODUCTION
Progressive facial hemiatrophy, also known as Parry-Romberg 
syndrome, is a rare disease (1/700,000), which usually affects 
women. It begins in the first two decades of life; however, it has 
also been reported in the fifth or sixth decade with a mean age 
of presentation of 8.8 years. It is characterized by a progressive, 
self-limited deformation and reduction of the subcutaneous tis-
sue volume on one side of the face, which involves scar-like skin 
changes, atrophy of the subcutaneous and adipose tissue, circum-
scribed osteoporosis, trigeminal neuralgia, and changes in the 
hair and eyes [1].
The first sign of this disease is thinning of the skin and subcu-
taneous tissue, often preceded by a discoloration of the hair or 
alopecia areata. It may also involve the mouth, nose or ear, and 
damage is usually limited to a trigeminal area and it usually does 
not cross the midline. The final result is a craniofacial asymme-
try, which not only causes aesthetic discomfort, but also weak-
ens self-esteem, affecting growth and intellectual development 
of the patient [2].
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Progressive facial hemiatrophy, also known as Parry-Romberg syndrome, is a progressive and 
self-limited deformation of the subcutaneous tissue volume on one side of the face that 
creates craniofacial asymmetry. We present the case of a patient with a five-year history 
of progressive right facial hemiatrophy, who underwent facial volumetric restoration using 
cell-assisted lipotransfer (CAL), which consists of an autologous fat graft enriched with 
adipose-derived stem cells (ASCs) extracted from the same patient. ASCs have the capacity 
to differentiate into adipocytes. They also promote angiogenesis, release angiogenic growth 
factors, and some can survive as stem cells. The use of autologous fat as a filler in soft tissue 
atrophy has been satisfactory in patients with mild and moderate Parry-Romberg syndrome. 
Currently, CAL has showed promising results in the long term by decreasing the rate of fat 
reabsorption. The permanence and stability of the graft in all the injected areas has showed 
that autologous fat grafts enriched with stem cells could be a promising technique for the 
correction of defects caused by this syndrome.
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Throughout history many procedures have been described in 
an attempt to increase the volume lost by gradual atrophy of soft 
tissues: dermis-fat grafts, omental free flaps, and musculoskeletal 
free flaps, just to mention a few. Currently the use of a fat transfer 
to replenish volume is an increasingly popular method in the 
field of craniofacial surgery [3]. The introduction of liposuction 
and liposculpture techniques by Illouz [4] and Fournier and Ot-
teni [5] was a milestone in the history of autologous fat transfer. 
Subsequently, Coleman [6] indicated that the reabsorption of in-
jected fat is a constant and would require repeated injection. This 
led him to describe better methods for the aspiration, processing 
and application of fat, which includes thin cannulas, decantation, 
centrifugation, and filtration of the lipoaspirate.
Matsumoto et al. [7] described a technique called cell-assisted 
lipotransfer (CAL) that consists of an autologous adipose tissue 
transplant enriched with adipose-derived stem cells (ASCs). Us-
ing enzymatic digestion with collagenase and centrifugation a cell 
pellet known as the stromal vascular fraction (SVF) that contains 
stromal cells, endothelial progenitor cells, ASCs, preadipocytes, 
and is devoid of adipocytes, is used to enrich the fat graft to be 
injected.
ASCs from the SVF have several advantages: they can differ-
entiate directly into adipocytes and contribute to adipose tissue 
regeneration, promote angiogenesis and survival of the graft 
through differentiation into endothelial cells, release angiogenic 
growth factors in response to injury and hypoxia and finally, 
some can survive as stem cells. Yoshimura et al. [8,9] used this 
technique in patients with facial lipoatrophy and cosmetic breasts 
augmentation with excellent results.
CASE
The patient is a 35-year-old man with no previous medical his-
tory, diagnosed with progressive right hemifacial atrophy of 10 
years evolution and 5 years with a stabilized condition. On exam-
ination, alopecia was found in the parietal and temporal region, 
together with subcutaneous tissue atrophy of the temporal region 
and the right midface, tooth loss, decreased range of motion of 
the temporomandibular joint, and trigeminal neuralgia. Comput-
ed tomography with 3-dimensional (3D) reconstruction showed 
Table 1. Injected volume per facial zone 
 Facial region Injected volume (mL)
 Temporal region 15 
 Cheek 25 
 Lips   3 
 Malar region 15 
 Mandibular region and base of the neck 35 
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Fig. 1. A 35-year-old male patient diagnosed with Parry-Romberg syndrome
(A, C, E) Preoperative view. (B, D, F) Postoperative view 12 months after 
lipoinjection enriched with stem cells and elements of the stromal 
vascular fraction. 
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the absence of the temporomandibular joint and a significant 
reduction of tissue volume in the affected side.
We preformed a previous analysis of the degree of atrophy 
marking the face with 18 squares using four horizontal planes 
crossed by seven vertical planes. This helped us identify the areas 
and volume to inject for facial volume replacement under general 
anesthesia. We infiltrated the skin with a tumescent Klein solu-
tion (solucion HT 1,000 mL with epinephrine 1 mg/mL, PiSA 
Farmaceutica Mexicana, SA de CV, Guadalajara, Mexico) in the 
periumbilical region and continued with fat extraction with a 
3-mm blunt cannula connected to a 20 mL syringe. We extracted 
a total of 300 mL of fat, from which we separated 150 mL for 
processing and extraction of the ASCs. We followed the proce-
dure described by Yoshimura et al. [8,9] (except for the isolation 
of stem cells from the fluid portion): digestion with collagenase, 
type II (Gibco, Invitrogen, Carlsbad, CA, USA) and centrifuga-
tion (800×g, 10 minutes), with a duration of approximately 
90 minutes. With the resulting pellet we enriched the 150 mL 
initially separated. For injection we used 1 and 3 mL syringes 
connected to a 2-mm blunt cannula; 50% of the enriched fat was 
injected into the submuscular layer, and the remaining fat in the 
subcutaneous stratum (Table 1).
DISCUSSION
The postoperative evolution of our patient in the short and long 
term (1 and 12 months) was satisfactory (Fig. 1). Infiltration 
with enriched autologous fat containing ASCs reduced the severe 
depression of the frontotemporal region, and provided better 
volume and symmetry. An acceptable improvement of the malar 
prominence and cheek was also achieved, with greater volume 
and projection on the front view and profile. The contour of the 
mandibular border from the angle to the chin was redefined, 
achieving a better balance, even the neck base benefitted volu-
metrically. It is important to point out the permanence of the fat 
graft in the lips, which allows the teeth to be hidden because of 
the increase in lip volume. The permanence of the graft remained 
stable in all the injected areas, even in the nasolabial folds and 
lips, which are areas of maximum mobility and reabsorption.
Finally, from our point of view and also that of the patient, an-
other important aspect with this technique, which has not been 
reported in the literature, is the clinical improvement of skin qual-
ity: better moisture, texture, shine, and even elasticity.
Soft tissue involvement in Parry-Romberg syndrome is global, 
including the craniofacial skeleton. It may have varying degrees 
of atrophy and hence the facial asymmetry is more evident. Al-
though there is no treatment for the underlying etiology, clinical 
protocols with immunomodulatory drugs are being performed. 
Currently, we focus therapy on restoring volume and improving 
facial expressions.
The literature has reported better results when aspirated fat is 
processed with Coleman’s method, which has less reabsorption 
and more predictable results. The use of autologous fat as a filler 
has been quite acceptable in patients with soft tissue atrophy, 
such as in Parry-Romberg syndrome. For this reason, we pro-
pose the combination of autologous fat transplant with SVF ele-
ments that contain ASCs. This technique could be considered 
standard treatment [10,11].
A larger study with more patients will provide the basis for un-
derstanding the involvement of ASCs, not only as an adjunct for 
tissue regeneration, but also for the skin itself. In the near future 
we consider that its use will be the beginning of a new treatment 
strategy for patients with different degrees of soft tissue atrophy.
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